JPRN-UMIN000004733
Completed
未知
Prospective cohort study on dialysis associated spondylosis(DAS) of dialysis related amyloidosis(DRA) patients in Japan (PCDJ) - Prospective cohort study on DAS of DRA patients in Japan (PCDJ)
beta2-microgloblin removal therapy study group0 sites600 target enrollmentStarted: December 16, 2010Last updated:
ConditionsDialysis related amyloidosis
Overview
- Phase
- 未知
- Status
- Completed
- Sponsor
- beta2-microgloblin removal therapy study group
- Enrollment
- 600
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1\)Patients who have a medical history of surgery for diseases in cervical spine of lumbar spine (2\)Patients who are complicated by Rheumatoid arthritis (3\)Patients who were considrered as ineligible for this trial by the attending doctor
Investigators
Similar Trials
Recruiting
Not Applicable
Kyusyu Prospective Cohort Study in Hemodialysis PatientsChronic hemodialysis patientsJPRN-UMIN000033365ARO Next Generation Medical Center3,600
Completed
Phase 4
The effects of irbesartan and nebivolol on ambulatory blood pressure in patients with intradialytic hypertension.Patients with end-stage renal disease on hemodialysis with intradialytic hypertensionUrological and Genital DiseasesEnd-stage renal diseaseISRCTN13587185Aristotle University of Thessaloniki School of Medicine38
Recruiting
Phase 1
A pilot study for chronic dialysis patients: Safety study using CV port and new needle for blood return of chronic dialysis patientsJPRN-jRCTs032200024Yamagata Kunihiro5
Completed
Not Applicable
A retrospective study on perioperative dialysis of TAVI and AVR in patients receiving maintenance hemodialysis with severe aortic valve stenosis.Aortic valve stenosis. End-stage kidney disease.JPRN-UMIN000046157Department of Nephrology, Endocrinology and Diabetes, Tokyo Bay Urayasu Ichikawa Medical Center50
Active, not recruiting
Not Applicable
A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process - NDProphylactic vaccination against infection with hepatitis B virus in renal predialysis and dialysis patientsMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiencyEUCTR2006-003650-20-ITMerck and Co Inc.276